Atlas Trials

A Study Evaluating the Effectiveness of PEA Compared to Placebo for Reducing Pain Severity and Duration of Migraines.

Clinical trial NCT05046522 · COMPLETED

Trial details

NCT number
NCT05046522
Sponsor
RDC Clinical Pty Ltd
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Migraine
Start date
2021-09-01
Primary completion
2023-03-09
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.